Oscar Health (OSCR)
NYSE Markedet er stengt
Oscar Health, Inc. is a health insurance and healthcare technology company built around a digital-first operating model. The company is best known for selling Individual and Family health plans through federal and state Affordable Care Act exchanges, where consumers purchase coverage either directly or with the help of subsidies and marketplace tools.
Oscar combines traditional insurance functions with a proprietary technology platform designed to improve member service, care navigation, claims handling, and plan administration. Its model emphasizes a consumer-facing app, virtual care access, member engagement, and data-driven support tools. The company’s goal is to make health insurance easier to use while managing medical costs and improving the experience for members navigating doctors, prescriptions, claims, and benefits.
In addition to its insurance products, Oscar provides health technology solutions through its platform capabilities. These services are intended to support parts of the healthcare ecosystem that need modernized administration, engagement, or operational tools. The company reports its business as a single operating segment, reflecting its integrated approach to insurance and technology rather than a collection of unrelated divisions.
Oscar’s market opportunity is closely linked to the ACA exchange system, consumer adoption of individual health plans, healthcare cost trends, and regulatory developments in U.S. health insurance. As a public company, it is often viewed as a technology-enabled insurer: its differentiation depends not only on underwriting and network management, but also on whether its platform can deliver a better member experience and support profitable growth in a highly regulated, competitive market.
Sist oppdatert
- Markedsverdi
- 7.12B
- P/E-tall
- —
- P/FCF-tall
- 2.54
- P/S-tall
- 0.54
- Selskapsverdi
- 2.74B
- Sektor
- Financials
- Bransje
- Hospital and Medical Service Plans
- Adresse
- 75 VARICK STREET, NEW YORK, NY, 10013
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
Wall Street Bulls Look Optimistic About Oscar Health (OSCR): Should You Buy?
Oscar Health (OSCR) Is Attractively Priced Despite Fast-paced Momentum
Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?
Fast-paced Momentum Stock Oscar Health (OSCR) Is Still Trading at a Bargain
Oscar Health, Inc. (OSCR) Surpasses Q1 Earnings and Revenue Estimates
Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar?
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?
Prudential (PRU) Lags Q1 Earnings Estimates
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
Why Fast-paced Mover Oscar Health, Inc. (OSCR) Is a Great Choice for Value Investors
Despite Fast-paced Momentum, Oscar Health, Inc. (OSCR) Is Still a Bargain Stock
Oscar Health, Inc. (OSCR) Is Attractively Priced Despite Fast-paced Momentum
Oscar Health, Inc. (OSCR) Shows Fast-paced Momentum But Is Still a Bargain Stock
November Marks Best Month Since 2022: 4 Best Sectors & Stock Picks
Oscar Health, Inc. (OSCR) is a Great Momentum Stock: Should You Buy?
Wall Street Analysts Believe Oscar Health, Inc. (OSCR) Could Rally 59.34%: Here's is How to Trade
- Markedsverdi
Markedsverdi er den samlede verdien av et selskaps aksjer, beregnet ved å multiplisere aksjekursen med antall utestående aksjer.
- 7.12B
- Selskapsverdi
Enterprise value er den samlede verdien av et selskap, inkludert markedsverdi, gjeld og kontanter.
- 2.74B
- P/E-tall
P/E-forholdet sammenligner en aksjekurs med resultat per aksje.
- —
- P/B-tall
P/B-forholdet sammenligner en aksjekurs med bokført verdi per aksje.
- 4.28
- P/S-tall
P/S-forholdet sammenligner en aksjekurs med omsetning per aksje.
- 0.54
- EV / EBITDA-forhold
EV/EBITDA måler et selskaps verdi mot resultat før renter, skatt, avskrivninger og amortiseringer.
- -15.43
- EV / omsetning
EV/omsetning måler et selskaps verdi mot total omsetning.
- 0.21
- Resultat per aksje
- -0.13
- Utbytterente
Utbytterente viser hvor mye et selskap betaler i utbytte per år sammenlignet med aksjekursen.
- 0%
- P/FCF-tall
Forholdet kurs til fri kontantstrøm sammenligner aksjekursen med kontanter etter utgifter og investeringer.
- 2.54
- P/CF-tall
P/CF-forholdet sammenligner aksjekursen med kontantstrøm fra driften.
- 2.51
- Fri kontantstrøm
Fri kontantstrøm er kontanter etter driftskostnader og kapitalutgifter.
- 2.8B
- Avkastning på egenkapital
ROE måler hvor effektivt et selskap bruker egenkapital til å skape overskudd.
- -2.37%
- Avkastning på eiendeler
ROA måler hvor effektivt et selskap bruker eiendeler til å skape overskudd.
- -0.42%
- Gjeld / egenkapital
Gjeld-til-egenkapital-forholdet sammenligner total gjeld med egenkapital.
- 0.26
- Likviditetsgrad I
Likviditetsgrad I måler evnen til å betale kortsiktig gjeld med omløpsmidler.
- 1.09
- Likviditetsgrad II
Likviditetsgrad II måler evnen til å betale kortsiktig gjeld med kontanter og lett realiserbare midler.
- 1.09
- Kontanter
Kontantgraden måler evnen til å dekke kortsiktig gjeld kun med kontanter og kontantekvivalenter.
- 0.67
- Snittvolum
Snittvolum viser gjennomsnittlig antall aksjer omsatt de siste 30 handelsdagene og indikerer likviditet.
- 8.03M
- Fundamentalpris (snapshot)
Fundamentalpris (snapshot) er aksjekursen som brukes ved beregning av selskapets finansielle nøkkeltall.
- 23.6
Resultatregnskap
| Post | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Omsetning | 4.59B | 2.76B | 2.93B | 2.81B | 3B |
| Bruttofortjeneste | 1.36B | 135.55M | 346.44M | 256.97M | 740.5M |
| Driftsresultat | 643.47M | -383.36M | -182.47M | -284.49M | 251.01M |
| Driftsresultat før avskrivninger (EBITDA) | 650.49M | -375.48M | -175.15M | -277.52M | 257.74M |
| Nettoresultat | 679M | -352.61M | -137.45M | -228.36M | 275.27M |
| Grunnleggende EPS | 2.28 | -1.34 | -0.53 | -0.89 | 1.1 |
| Utvanet EPS | 2.07 | -1.34 | -0.53 | -0.89 | 0.92 |
Balanse
| Post | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Sum eiendeler | 9.29B | 6.33B | 5.75B | 6.38B | 5.84B |
| Sum gjeld | 7.62B | 5.34B | 4.72B | 5.22B | 4.51B |
| Egenkapital | 1.67B | 980.74M | 1.03B | 1.16B | 1.34B |
| Kontanter og ekvivalenter | 4.81B | 2.77B | 2.15B | 2.6B | 2.24B |
| Omløpsmidler | 7.78B | 4.61B | 3.76B | 4.31B | 3.77B |
| Kortsiktig gjeld | 7.14B | 4.86B | 3.98B | 4.87B | 4.15B |
Kontantstrøm
| Post | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Kontantstrøm fra drift | 2.62B | 671.9M | -964.66M | 509.07M | 878.54M |
| Kontantstrøm fra investeringer | -590.25M | -48.71M | 150.08M | -168.21M | -174.23M |
| Kontantstrøm fra finansiering | -3.6M | 8.17M | 364.03M | 22.13M | 4.87M |
| Endring i kontanter | 2.03B | 631.37M | -450.54M | 362.99M | 709.19M |
| Type | Rapport | Dato | Lenke |
|---|---|---|---|
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 8-K — Oscar Health, Inc. | Vis rapport | |
| eight k text | 8-K — 8-K | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| edgar index | 10-Q — Oscar Health, Inc. | Vis rapport | |
| edgar index | 8-K — Oscar Health, Inc. | Vis rapport | |
| eight k text | 8-K — 8-K | Vis rapport | |
| edgar index | DEF 14A — Oscar Health, Inc. | Vis rapport | |
| edgar index | DEFA14A — Oscar Health, Inc. | Vis rapport | |
| edgar index | ARS — Oscar Health, Inc. | Vis rapport | |
| edgar index | 8-K — Oscar Health, Inc. | Vis rapport | |
| eight k text | 8-K — 8-K | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| form 4 | Form 4 — BOYD JEFFERY H | Vis rapport | |
| form 4 | Form 4 — Sankaran Sid | Vis rapport | |
| form 4 | Form 4 — Plouffe David | Vis rapport | |
| form 4 | Form 4 — Gassen William | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| form 4 | Form 4 — Bertolini Mark T | Vis rapport | |
| form 4 | Form 4 — Bertolini Mark T | Vis rapport | |
| form 4 | Form 4 — Bertolini Mark T | Vis rapport | |
| form 4 | Form 4 — Bertolini Mark T | Vis rapport | |
| edgar index | SCHEDULE 13G/A — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 144 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 8-K — Oscar Health, Inc. | Vis rapport | |
| eight k text | 8-K — 8-K | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| form 4 | Form 4 — Blackley Richard Scott | Vis rapport | |
| form 4 | Form 4 — Schlosser Mario | Vis rapport | |
| form 4 | Form 4 — Schlosser Mario | Vis rapport | |
| form 4 | Form 4 — McAnaney Adam | Vis rapport | |
| form 4 | Form 4 — McAnaney Adam | Vis rapport | |
| form 4 | Form 4 — Baltrus Victoria | Vis rapport | |
| form 4 | Form 4 — Baltrus Victoria | Vis rapport | |
| form 4 | Form 4 — Bertolini Mark T | Vis rapport | |
| form 4 | Form 4 — Liang Janet | Vis rapport | |
| form 4 | Form 4 — Liang Janet | Vis rapport | |
| edgar index | SCHEDULE 13G/A — Oscar Health, Inc. | Vis rapport | |
| edgar index | S-8 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 10-K — Oscar Health, Inc. | Vis rapport | |
| ten k section | 10-K — business | Vis rapport | |
| ten k section | 10-K — mda | Vis rapport | |
| ten k section | 10-K — risk_factors | Vis rapport | |
| edgar index | 8-K — Oscar Health, Inc. | Vis rapport | |
| eight k text | 8-K — 8-K | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport | |
| edgar index | 4 — Oscar Health, Inc. | Vis rapport |